Fusion protein for inhibiting cervical cancer

Details Fusion protein for inhibiting cervical cancer Fusion protein for inhibiting cervical cancer

C - Chemistry, Metallurgy

07

K

C07K 19/00 (2006.01) A61K 38/16 (2006.01) A61K 39/00 (2006.01) A61K 39/104 (2006.01) A61K 39/12 (2006.01) A61K 39/395 (2006.01) A61P 31/20 (2006.01) A61P 35/00 (2006.01) C07K 14/025 (2006.01) C07K 14/21 (2006.01) C07K 16/08 (2006.01) C07K 16/12 (2006.01)

Patent

CA 2516511

A fusion protein for inhibiting cervical cancer is disclosed, which comprises a peptide sequence of human papillomavirus type 16, a peptide translocating peptide for translocation, and a peptide within a carboxyl terminal fragment. The present invention further comprising a composition of antibody, which conjugates to E7 peptide, wherein the nucleotide sequence corresponding to the amino acid sequence of the E7 peptide is shown as SEQ. ID. NO.1.

Affiliated with

Also associated with

Rating

Fusion protein for inhibiting cervical cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fusion protein for inhibiting cervical cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion protein for inhibiting cervical cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2021063